Allo-HSCT: Clinical Trials

10 trials of Allo-HSCT, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 3 unknown, 2 not yet recruiting, 1 active not recruiting. 3 Not applicable, 3 Phase 2, 2 Early Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable3Not yet recruiting 2, Unknown 1
Phase 23Unknown 2, Active not recruiting 1
Early Phase 12Recruiting 2
Phase 32Unknown 2

Follow Allo-HSCT: new trials by email Literature Review of Allo-HSCT trials Research Report on Allo-HSCT

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML
Venetoclax (VEN), Azacitidine (AZA), Allo-HSCT - Hypoplastic Acute Myeloid Leukemia, Secondary AML (Adult)
Not applicableNot yet recruitingThe First Affiliated Hospital of Soochow University502026-06-012026-06-09
Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
Autologous Hematopoietic Stem Cell Transplantation, Allogenic stem cell transplant (ASCT) - Peripheral T Cell Lymphoma
RecruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine882025-12-312025-12-23
CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases
CD7 CAR-T cells injection, Allo-HSCT - Bone Marrow Failure Syndrome
Early Phase 1RecruitingZhejiang University202025-01-312025-01-22
Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD
CD7 CAR-T cells injection, Allo-HSCT, Kidney Transplantation - Schimke Immuno-osseous Dysplasia
Early Phase 1RecruitingZhejiang University202025-01-302025-01-20
Allo-HSCT vs ASCT in Adult T-LBL
ASCT, Allo-HSCT - T Lymphoblastic Lymphoma
Not applicableNot yet recruitingPeking University People's Hospital2302025-01-012024-12-19
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
sonrotoclax, idarubicin/daunorubicin, Cytarabine - Acute Myeloid Leukemia
Phase 2Active not recruitingShanghai Jiao Tong University School of Medicine472024-10-302026-04-30
The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission
allo-HSCT - AML
Not applicableUnknownNational Research Center for Hematology, Russia752021-02-012022-04-21
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
Dexamethasone, vincristine, Cyclophosphamide - Leukemia, Leukemia, Acute
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University802016-02-142018-06-21
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
Chidamide, Dexamethasone, vincristine - Leukemia, Acute, Leukemia, T Cell
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University702016-02-142018-06-12
Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)
Allo-HSCT - X-Linked Adrenoleukodystrophy (X-ALD), Cerebral Adrenoleukodystrophy (CALD)
TerminatedGenetix Biotherapeutics Inc.592015-04-012020-05-21

Conditions studied

Leukemia (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, T-Cell (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Adrenoleukodystrophy (1)  ·  Bone Marrow Failure Disorders (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Schimke immunoosseous dysplasia (1)

Sponsors

Nanfang Hospital, Southern Medical University (2)  ·  Zhejiang University (2)  ·  Genetix Biotherapeutics Inc. (1)  ·  National Research Center for Hematology, Russia (1)  ·  Peking University People's Hospital (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)  ·  Shanghai Jiao Tong University School of Medicine (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (7)  ·  Argentina (1)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

He Huang, MD (2)  ·  Elizabeth McNeil, MD MSc (1)  ·  Hongsheng Zhou, MD, PhD (1)  ·  Junmin Li (1)  ·  Qifa Liu, MD (1)  ·  Suning Chen, Doctor (1)

Results publications

PMID 34781360, PMID 39468701, PMID 40008672